| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/25/2009 | EP1353692B1 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 03/25/2009 | EP1050301B1 Medicinal compositions containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| 03/25/2009 | CN101392267A Therapeutic effects of Math1 gene pairs forsensorineural hearing loss |
| 03/25/2009 | CN101391075A Mixed traditional Chinese medicine health-care pillow |
| 03/25/2009 | CN101391071A Traditional Chinese medicine for treating diabetic ocular fundus diseases |
| 03/25/2009 | CN101390997A Jianmu capsule and preparation method thereof |
| 03/25/2009 | CN101390973A Use of traditional Chinese medicine in preparing medicine for treating retinal vein obstruction |
| 03/25/2009 | CN101390943A Traditional Chinese medicine preparation for improving acuity of vision and emoving nebula, tranquilizing and allaying excitement, reducing fever and nourishing liver and preparation method thereof |
| 03/25/2009 | CN101390874A Eye health preparation |
| 03/25/2009 | CN101390862A Medicine composition containing mizolastine and preparation method thereof |
| 03/25/2009 | CN101390836A Antifungal activity ophthalmopathy slow-release microparticle and use thereof |
| 03/25/2009 | CN101390834A Eye amphotericin B flexible liposome |
| 03/25/2009 | CN101390825A Intra-ocular release system of voriconazole |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471509C Medicine for treating tympanitis and otitis externa, and preparing method |
| 03/24/2009 | US7507841 Cannabinoid receptor modulator |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507712 NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | CA2407715C Diagnostics and therapeutics for macular degeneration-related disorders |
| 03/24/2009 | CA2356745C Ionic aqueous composition containing levomenthol |
| 03/24/2009 | CA2320717C Method for the treatment of diseases or disorders of the inner ear |
| 03/24/2009 | CA2264626C Pharmaceutical composition containing lornoxicam and a disodium salt of edta |
| 03/19/2009 | WO2009036149A2 Methods for treatment of degenerative disease associated with apoptosis |
| 03/19/2009 | WO2009036108A1 Methods and compositions for inhibiting vascular leakage |
| 03/19/2009 | WO2009035534A2 Treatment of ischemic eye disease by the systematic pharmaceutical activation of hypoxia inducible factor (hif) |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009035034A1 Ophthalmic composition |
| 03/19/2009 | WO2009035033A1 Ophthalmic composition |
| 03/19/2009 | WO2009033652A1 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus |
| 03/19/2009 | WO2009033651A1 Titration package for neramexane and its use in the treatment of an inner ear disorder |
| 03/19/2009 | WO2009033650A1 1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss |
| 03/19/2009 | WO2009033649A1 Interval therapy for the treatment of tinnitus |
| 03/19/2009 | WO2009007348A3 Use of antagonists of g protein coupled receptors (gpcrs) for treating diseases caused by agonistic autoantibodies activated gpcrs |
| 03/19/2009 | WO2009002790A3 Compositions and methods for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | WO2008070579A3 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090076256 Degradation-resistant mononucleoside phosphate compounds |
| 03/19/2009 | US20090076160 Use of R (+) -N-propargyl-1-aminoindan to treat or prevent hearing loss |
| 03/19/2009 | US20090076150 Deuterium-enriched bromfenac |
| 03/19/2009 | US20090076080 Deuterium-enriched fexofenadine |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075927 Sweet taste receptors |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090074847 Transport System In Biological Systems |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/19/2009 | US20090074807 Moraxella (branhamella) catarrhalis antigens |
| 03/19/2009 | US20090074795 Methods for addressing ocular diseases through interference with the wnt signaling pathway |
| 03/19/2009 | US20090074786 Formulations for treating ocular diseases and conditions |
| 03/19/2009 | US20090074739 Pharmacological vitreolysis |
| 03/19/2009 | US20090074723 Method of Treating or Retarding the Development of Blindness |
| 03/19/2009 | CA2699213A1 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus |
| 03/19/2009 | CA2699210A1 Titration package for neramexane and its use in the treatment of an inner ear disorder |
| 03/19/2009 | CA2699209A1 1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss |
| 03/19/2009 | CA2699207A1 Interval therapy for the treatment of tinnitus |
| 03/19/2009 | CA2698980A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698693A1 Use of a peptide as a therapeutic agent |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2035023A1 Prevention and treatment of otitis media with non-pathogenic bacterial strains |
| 03/18/2009 | EP2035015A2 Compositions, methods, and kits for treating dry eye |
| 03/18/2009 | EP2035004A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 03/18/2009 | EP2034838A2 Novel compounds |
| 03/18/2009 | EP2000483A9 Vegf receptor fusion protein and use thereof |
| 03/18/2009 | EP1948131B1 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 03/18/2009 | EP1819366B1 A staining composition for staining an ophthalmic membrane |
| 03/18/2009 | EP1663987B1 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2009 | EP1462112B1 Remedies for dry eye and diseases associated with dry eye |
| 03/18/2009 | CN101385824A Medicine for treating glaucoma, cataract, pinkeye and near sightedness and preparation method thereof |
| 03/18/2009 | CN101385804A New use of traditional Chinese medicine formulation |
| 03/18/2009 | CN101385770A Blueberry chrysanthemum capsules and preparation method thereof |
| 03/18/2009 | CN101385769A Blueberry pearl chewing tablet and preparation method thereof |
| 03/18/2009 | CN101385728A Eye drip preparation of balofloxacin or salt thereof and preparation method thereof |
| 03/18/2009 | CN101385703A Cation adhesion type natamycin nano eye drops |
| 03/18/2009 | CN101385697A Flurbiprofen axetil eye nano-emulsion in-situ gel preparation and preparation method thereof |
| 03/18/2009 | CN100469887C Carotene synthase gene and uses therefor |
| 03/18/2009 | CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469765C Prostaglandin nitrooxyderivatives |
| 03/18/2009 | CN100469368C Use of adatanserin for treating neurogenerative disorders |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/12/2009 | WO2009031851A2 Retractable brush |
| 03/12/2009 | WO2009031682A1 EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE |
| 03/12/2009 | WO2009031575A1 Therapeutic or prophylactic agent for posterior ocular disease comprising lithium salt as active ingredient |
| 03/12/2009 | WO2009030890A1 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| 03/12/2009 | WO2009013435A3 Preservative-free prostaglandin-based ophthalmic solution |
| 03/12/2009 | WO2009010871A3 Pyrazole derivatives as antagonists of adenosine a3 receptor |
| 03/12/2009 | WO2008124151A3 Use of creatine compounds for the treatment of eye disorders |